2 months ago
NTRA
AnalystsSubbu NambiSubbu Nambi's Stock Forecasts
AnalystsSubbu Nambi
Analyst Ranking
Top 1%
#43 out of 5523 analysts
Average Return
+85.7%
Win Rate
75%71 out of 95
Risk vs Reward
Poor
Good
Subbu Nambi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +4,095.93% | $44.45 | $1,865.09 | 2025-04-11 - 2026-03-24 | Strong Buy |
Twist Bioscience CorpTWST | +322.99% | $42.46 | $179.60 | 2026-01-26 - 2026-09-28 | Strong Buy |
Twist Bioscience CorpTWST | +315.16% | $43.26 | $179.60 | 2026-03-30 - 2026-09-28 | Strong Buy |
Twist Bioscience CorpTWST | +216.75% | $56.70 | $179.60 | 2026-05-05 - 2026-09-28 | Strong Buy |
Guardant Health IncGH | +193.20% | $60.18 | $176.45 | 2025-09-25 - 2026-09-24 | Strong Buy |
Subbu Nambi Analyst Color
Get additional color on Subbu Nambi's coverage of popular stocks
2 months ago
ADPT
2 months ago
GH
3 months ago
WGS
3 months ago
VCYT
3 months ago
TWST
3 months ago
NTRA
3 months ago
GH
3 months ago
BLLN
3 months ago
ADPT
5 months ago
BLLN
5 months ago
TWST
5 months ago
CYRX
6 months ago
TWST
7 months ago
NAUT
8 months ago
TWST
8 months ago
SOPH
8 months ago
PSNL
8 months ago
GRAL
8 months ago
GH
8 months ago
CSTL
8 months ago
ADPT
9 months ago
VCYT
9 months ago
NTRA
9 months ago
GH
Subbu Nambi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Freenome IncFRNM | 1 | Strong Buy | $21.00 | +29.71% | Initiates Coverage On | a month ago |
Natera IncNTRA | 5 | Strong Buy | $360.00 | -12.57% | Maintains | 2 months ago |
Cryoport IncCYRX | 3 | Strong Buy | $16.00 | -7.94% | Maintains | 2 months ago |
Illumina IncILMN | 8 | Strong Buy | $226.00 | -16.88% | Maintains | 2 months ago |
Adaptive Biotechnologies CorpADPT | 5 | Strong Buy | $25.00 | -12.31% | Maintains | 2 months ago |
Danaher CorpDHR | 5 | Strong Buy | $200.00 | -12.02% | Maintains | 2 months ago |
Tempus Ai IncTEM | 6 | Strong Buy | $65.00 | -23.60% | Maintains | 2 months ago |
Guardant Health IncGH | 10 | Strong Buy | $190.00 | +7.14% | Maintains | 2 months ago |
Waters CorpWAT | 2 | Strong Buy | $440.00 | -0.66% | Reiterates | 3 months ago |
Genedx Holdings CorpWGS | 5 | Strong Buy | $74.00 | -13.88% | Maintains | 3 months ago |
Veracyte IncVCYT | 7 | Strong Buy | $65.00 | +43.71% | Maintains | 3 months ago |
Twist Bioscience CorpTWST | 6 | Strong Buy | $107.00 | -40.42% | Maintains | 3 months ago |
Bruker CorpBRKR | 7 | Strong Buy | $70.00 | +10.62% | Maintains | 3 months ago |
Billiontoone IncBLLN | 4 | Strong Buy | $125.00 | +2.69% | Initiates Coverage On | 3 months ago |
Grail IncGRAL | 4 | Strong Buy | $75.00 | -43.45% | Maintains | 6 months ago |
Nautilus Biotechnology IncNAUT | 2 | Strong Buy | $4.00 | +260.36% | Maintains | 7 months ago |
Sophia Genetics SaSOPH | 2 | Strong Buy | $7.00 | -17.55% | Maintains | 8 months ago |
Personalis IncPSNL | 2 | Strong Buy | $13.00 | -20.34% | Maintains | 8 months ago |
Castle Biosciences IncCSTL | 3 | Strong Buy | $47.00 | +30.81% | Maintains | 8 months ago |
Neogen CorpNEOG | 4 | Strong Buy | $12.00 | -12.54% | Maintains | 9 months ago |
Exact Sciences CorpEXAS | 4 | Hold | N/A | N/A | Downgrades | 10 months ago |
Revvity IncRVTY | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Caris Life Sciences IncCAI | 2 | Strong Buy | $36.00 | N/A | Maintains | a year ago |
Myriad Genetics IncMYGN | 2 | Hold | N/A | N/A | Downgrades | a year ago |
10x Genomics IncTXG | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Repligen CorpRGEN | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Pacific Biosciences Of California IncPACB | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Akoya Biosciences IncAKYA | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.